EMD Serono

URI: https://gptkb.org/entity/EMD_Serono

GPTKB entity

Statements (76)

Predicate	Object
gptkbp:instance_of	gptkb:pharmaceuticals
gptkbp:acquired	gptkb:Serono
gptkbp:collaborates_with	academic institutions healthcare providers
gptkbp:employs	gptkb:scientists gptkb:researchers
gptkbp:engages_in	clinical trials
gptkbp:focus_area	biopharmaceuticals
gptkbp:founded	gptkb:2006
gptkbp:has_part	research facilities manufacturing plants
gptkbp:has_product	gptkb:Dupilumab gptkb:Atezolizumab gptkb:Nivolumab gptkb:Rituximab gptkb:Trastuzumab gptkb:Kymriah gptkb:Lapatinib gptkb:Osimertinib gptkb:Alectinib gptkb:Durvalumab gptkb:Bavencio gptkb:Idelalisib gptkb:Ruxolitinib gptkb:Tysabri gptkb:Guselkumab gptkb:Xolair gptkb:Ocrevus gptkb:Secukinumab gptkb:Upadacitinib gptkb:Vumerity gptkb:Aubagio gptkb:Lemtrada gptkb:Bevacizumab gptkb:Abatacept gptkb:Anakinra gptkb:Baricitinib gptkb:Belimumab gptkb:Benralizumab gptkb:Brentuximab_vedotin gptkb:Brodalumab gptkb:Canakinumab gptkb:Cinqair gptkb:Crizotinib gptkb:Egrifta gptkb:Entrectinib gptkb:Filgotinib gptkb:Ibrutinib gptkb:Ixekizumab gptkb:Mepolizumab gptkb:Pazopanib gptkb:Pertuzumab gptkb:Reslizumab gptkb:Risankizumab gptkb:Sarilumab gptkb:Tezepelumab gptkb:Tildrakizumab gptkb:Tocilizumab gptkb:Tofacitinib gptkb:Venetoclax gptkb:Zinbryta
gptkbp:headquarters	gptkb:Rockland,_Massachusetts
https://www.w3.org/2000/01/rdf-schema#label	EMD Serono
gptkbp:offers	gptkb:Rebif gptkb:Gonal-f gptkb:Saizen Merck Serono products
gptkbp:operates_in	gptkb:Europe gptkb:Asia gptkb:North_America
gptkbp:parent_company	gptkb:Merck_KGa_A
gptkbp:specializes_in	gptkb:multiple_sclerosis endocrinology fertility treatments
gptkbp:bfsParent	gptkb:Merck_KGa_A
gptkbp:bfsLayer	4